|
|
Line 17: |
Line 17: |
| ==[[CAP Molecular Diagnosis of Lung Cancer]]== | | ==[[CAP Molecular Diagnosis of Lung Cancer]]== |
|
| |
|
| ===CAP Molecular Diagnosis of AML=== | | ==[[CAP Molecular Diagnosis of AML]]== |
| | |
| {{hidden|List 6 genes associated with Acute Myeloid Leukemia that have been identified by cloning translocation break points|RUNX1, RUNX1T1, PML, CBFB, ETV6, MLL}}
| |
| | |
| {{hidden|List the 5 main categories of classification of Acute Myeloid Leukemia|1. AML with recurrent genetic abnormalities, 2. AML with myelodysplasia-related changes, 3. Therapy related myeloid neoplasms, 4. AML, NOS, 5. Myeloid sarcoma}}
| |
| | |
| {{hidden|Give any three translocations identified in AML.|t(8,21), inv (16), t(15,17), t(9,11), t(6,9), inv(3), t(1,22), mutated NPM1, mutated CEBPA}}
| |
| | |
| {{hidden|What entities are fall under the AML, NOS classification?|AML with minimal differentiation, AML without maturation, AML with maturation, Acute myelomonocytic leukemia, Acute monoblastic/monocytic leukemia, Acute erythroid leukemias (pure erythroid, erythroleukemia, erythroid/myeloid), Acute Megakaryoblastic leukemia, Acute basophilic leukemia, Acte panmyelosis with myelofibrosis}}
| |
| | |
| {{hidden|List 2 genes which confer a poor prognostic impact vs 2 which confer a good prognostic impact.|Poor: KIT, FLT3, Good: NPM1, CEBPA}}
| |
| | |
|
| |
|
| === CAP Breast Cancer and Molecular === | | === CAP Breast Cancer and Molecular === |